Definium Therapeutics unveiled the second of two positive Phase 3 studies for its LSD-based drug. The biotech stock surged on the results. The post This LSD-Based Drug Just Scored Again. Definium Stock Soars. appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real